CR Sanjiu Pharma Acquires Shenghuo Pharma for $280 Million

China Resources Sanjiu Pharma will pay $280 million to acquire Kunming Shenghuo Pharmaceutical Group, a TCM company. Shenghuo has three subsidiaries that interest Sanjiu: Shenghuo Pharma, Shenghuo Cosmetics and Shenghuo Import & Export. Shenghuo's hotel business is not included in the deal. Sanjiu is a listed subsidiary of state-owned company China Resources Pharma, which is expected to stage a $1 billion IPO in Hong Kong soon. More details.... Stock Symbol: (SHA: 000999) Share this with colleagues: // //